Home / Healthcare/ FDA clears Novo Nordisk’s diabetes drug to reduce cardiovascular risk

FDA clears Novo Nordisk’s diabetes drug to reduce cardiovascular risk


Comments / {{hitsCtrl.values.hits}} Views / Monday, 28 August 2017 00:09


Reuters: Novo Nordisk said on Friday the US Food and Drug Administration (FDA) approved an expanded use of its diabetes drug to reduce the risk of cardiovascular events such as heart attack and stroke.

1Novo Nordisk logo is seen in Bagsvaerd outside of Copenhagen, Denmark – REUTERS

This is the first time the FDA has cleared a diabetes drug for reducing risks of heart attack, stroke and cardiovascular deaths in patients with type 2 diabetes, the company said in a statement.

In December, the FDA had approved Eli Lilly and Co and Boehringer Ingelheim Pharmaceuticals Inc’s drug, Jardiance, to reduce the risk of cardiovascular death in patients with type 2 diabetes.

Novo Nordisk’s Victoza, which was approved in 2010 to treat patients with type 2 diabetes, brought in 11.5 billion Danish crown ($1.84 billion) in the first six months of 2017.

Type 2 diabetes, closely linked to obesity, accounts for more than 90% of all diabetes cases, the company said.

Victoza’s expanded label follows a successful trial that showed the drug significantly reduced the risk of cardiovascular death, non-fatal heart attack or non-fatal stroke by 13% when compared to a placebo.

Heart disease is the leading cause of death in the United States, killing about 610,000 people every year, according to the Centers for Disease Control and Prevention.

Adults with type 2 diabetes are up to four times more likely to develop cardiovascular disease, the company said.


Share This Article


COMMENTS

Today's Columnists

Why are interest rates high?

Wednesday, 20 September 2017

The general public is concerned about the high level of interest rates prevailing in the recent past. Interest rates influences the day-to-day life of ordinary people as it is the benchmark for all economic decisions.


Dream or nightmare?

Wednesday, 20 September 2017

An air of unreality pervades the country. What you see is not what it is; fact, truth, reality - mere words, having no intrinsic meaning. An illusion shrouds another illusion; a maya merely hides another ‘maya’, a bottomless pit of deception.


Some thoughts on ‘Vision 2025: A Country Enriched’

Wednesday, 20 September 2017

Recently, our Government unveiled a forward plan titled: ‘V2025: A Country Enriched’. It spells out the Government’s economic vision for many relevant areas, including development plans for our human resource.


Is Sri Lanka ready for the 2025 growth agenda?

Tuesday, 19 September 2017

The other day the President and Prime Minister launched the 2025 vision for Sri Lanka which was incidentally the third policy statement of the Government since coming to power in 2015. My view is that the continuous changes to policy is important and


Columnists More